Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 751 AL 765

Alzheimer's disease: is pacemaker implantation safe?

Osmonov D, Ozcan KS, Altay S, Erdinler I, Yildirim E, Türkkan C, Canga Y, Alper AT, Cakmak N, Gürkan K.

Am J Alzheimers Dis Other Demen. 2012 May;27(3):202-5. doi: 10.1177/1533317512444457. Epub 2012 Apr 20.

Impact of HIV and aging on neuropsychological function

Wendelken LA, Valcour V.

J Neurovirol. 2012 Aug;18(4):256-63. doi: 10.1007/s13365-012-0094-1. Epub 2012 Apr 14.

Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers

Steenland K, Karnes C, Seals R, Carnevale C, Hermida A, Levey A.

J Alzheimers Dis. 2012;31(2):265-75. doi: 10.3233/JAD-2012-111922.

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

Li FJ, Shen L, Ji HF.

J Alzheimers Dis. 2012;31(2):253-8. doi: 10.3233/JAD-2012-120349.

The neural basis of syntactic deficits in primary progressive aphasia

Wilson SM, Galantucci S, Tartaglia MC, Gorno-Tempini ML.

Brain Lang. 2012 Sep;122(3):190-8. doi: 10.1016/j.bandl.2012.04.005. Epub 2012 Apr 29.

Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease

Côté S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J, Laurin D.

Alzheimers Dement. 2012 May;8(3):219-26. doi: 10.1016/j.jalz.2011.03.012.

Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease

Kotze MJ, van Rensburg SJ.

Metab Brain Dis. 2012 Sep;27(3):255-66. doi: 10.1007/s11011-012-9296-8. Epub 2012 Apr 19.

The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment

Tarawneh R, Holtzman DM.

Cold Spring Harb Perspect Med. 2012 May;2(5):a006148. doi: 10.1101/cshperspect.a006148.

[Diabetes mellitus and dementia]

Tůma I.

Vnitr Lek. 2012 Apr;58(4):305-8.

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.

PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.

Guidelines for the management of cognitive and behavioral problems in dementia

Sadowsky CH, Galvin JE.

J Am Board Fam Med. 2012 May-Jun;25(3):350-66. doi: 10.3122/jabfm.2012.03.100183.

Vascular dementia

Korczyn AD, Vakhapova V, Grinberg LT.

J Neurol Sci. 2012 Nov 15;322(1-2):2-10. doi: 10.1016/j.jns.2012.03.027. Epub 2012 May 8.

Disturbance of emotion processing in frontotemporal dementia: a synthesis of cognitive and neuroimaging findings

Kumfor F, Piguet O.

Neuropsychol Rev. 2012 Sep;22(3):280-97. doi: 10.1007/s11065-012-9201-6. Epub 2012 May 11.

Study protocol for a randomized controlled trial of humor therapy in residential care: the Sydney Multisite Intervention of LaughterBosses and ElderClowns (SMILE)

Goodenough B, Low LF, Casey AN, Chenoweth L, Fleming R, Spitzer P, Bell JP, Brodaty H.

Int Psychogeriatr. 2012 Dec;24(12):2037-44. doi: 10.1017/S1041610212000683. Epub 2012 May 14.

Zinc diet and Alzheimer's disease: a systematic review

Loef M, von Stillfried N, Walach H.

Nutr Neurosci. 2012 Sep;15(5):2-12. doi: 10.1179/1476830512Y.0000000010. Epub 2012 Apr 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias